Therapeutic Use of Botulinum-A toxin in Neurogenic Detrusor Overactivity in Patient after Spinal Cord Injury and Multiple Sclerosis. A Prospective, Open Study with Comparison of Suburothelial and Intradetrusor Application of 300 U of Botox
Latest Information Update: 14 Aug 2023
Price :
$35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 12 Aug 2023 Status changed from recruiting to completed.
- 22 Aug 2011 Planned End Date changed to 21 Feb 2020.
- 22 Aug 2011 New trial record